detection of imidacloprid in biological fluids in a case of fatal insecticide intoxication
TRANSCRIPT
Accepted Manuscript
Case report
Detection of imidacloprid in biological fluids in a case of fatal insecticide in-toxication
Chiaki Fuke, Takumi Nagai, Kenji Ninomiya, Maki Fukasawa, Yoko Ihama,Tetsuji Miyazaki
PII: S1344-6223(13)00123-5DOI: http://dx.doi.org/10.1016/j.legalmed.2013.10.007Reference: LEGMED 1073
To appear in: Legal Medicine
Received Date: 17 December 2012Revised Date: 24 October 2013Accepted Date: 24 October 2013
Please cite this article as: Fuke, C., Nagai, T., Ninomiya, K., Fukasawa, M., Ihama, Y., Miyazaki, T., Detection ofimidacloprid in biological fluids in a case of fatal insecticide intoxication, Legal Medicine (2013), doi: http://dx.doi.org/10.1016/j.legalmed.2013.10.007
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customerswe are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, andreview of the resulting proof before it is published in its final form. Please note that during the production processerrors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Detection of imidacloprid in biological fluids in a case of fatal insecticide intoxication
Chiaki Fuke *, Takumi Nagai, Kenji Ninomiya, Maki Fukasawa, Yoko Ihama, Tetsuji
Miyazaki
Department of Forensic Medical Science, Graduate School of Medicine,
University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan
Abstract
Here, we describe a high-performance liquid chromatography/photodiode array
detector method for the detection of imidacloprid in biological fluids in a case of suicide
by ingestion of liquor mixed with Admire® Flowable insecticide (containing 20%
imidacloprid). A plastic bottle containing a cloudy liquid (concentration of ethanol in
the liquid was 150 mg/ml and that of imidacloprid was 50 mg/ml) was found near the
decedent. The biological fluids collected at autopsy were prepared by deproteinization
with acetonitrile. Zolpidem was used as an internal standard. The concentrations of
imidacloprid in femoral blood and cerebrospinal fluid were 105 µg/ml and 58.5 µg/ml,
respectively. Ethanol was also detected in the samples, with concentrations of 1.0 mg/ml
in femoral blood and 1.4 mg/ml in cerebrospinal fluid.
1. Introduction
Imidacloprid [1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine] is
a neonicotinoid insecticide in the chloronicotinyl nitroguanidine chemical family (Fig.
1). It was introduced in the Japanese market in 1992. Trade names for Bayer
CropScience’s imidacloprid products include Admire® and Hachikusan®.
Imidacloprid acts on several types of postsynaptic nicotinic acetylcholine receptors
(nAChRs) in the nervous system. In insects, these receptors are located exclusively
within the central nervous system. Following the binding of imidacloprid to the
nicotinic receptor, nerve impulses are spontaneously discharged at first; however,
subsequently, the neurons fail to propagate any signal [1].
There are various subtypes of mammalian nAChRs, all of which have a lower
binding affinity for imidacloprid than that observed in insects [1, 2]. Therefore, the
acute oral toxicity of imidacloprid in mammals is considered moderate [1]. For example,
the oral lethal dosage (LD50) in male rats is 420 mg/kg [3]. In mammals, imidacloprid is
mainly metabolized to 6-chloronicotinic acid and its glycine conjugate, and
5-hydroxyimidacloprid [1, 3].
Insecticide products containing imidacloprid are used worldwide; therefore,
occasionally, accidental intoxication or intentional self-intoxication with imidacloprid
occurs throughout the world [4-15]. Some fatal intoxication cases have been reported,
despite the relatively low toxicity of imidacloprid in mammals [6, 7, 9, 13, 14]. In this
report, we describe a high-performance liquid chromatography/photodiode array
detector (HPLC/PDA) detection method for the identification of imidacloprid in
biological fluids in a fatal intoxication case.
2. Case report
A man in his 70s, who was missing after a quarrel with his family, was found dead
near his ancestor’s grave. A plastic bottle containing a white liquid with an alcoholic
odor was found near the decedent. A medico-legal autopsy was performed 2 days after
the death. The man’s height was 154 cm and he weighed 56 kg. His face showed
congestion, and there were some viscous fluid in his mouth. There were no signs of
serious injury on the body. The heart, which weighed 430 g, showed left ventricular
hypertrophy without myocardial ischemic change or coronary artery stenosis. The left
and right lungs showed congestion and weighed 420 g and 610 g, respectively. Gastric
contents were a white viscous fluid (70 ml) with an unpleasant odor. Substantial
petechial bleeding was observed in the mucosa of the stomach and duodenum. The
abdomen had a surgical scar, and there were indications that the man had undergone
right hemicolectomy with an ileotransverse anastomosis in the abdominal cavity. There
was no evidence of a lethal disease.
3. Materials and methods
3. 1. Chemicals
Imidacloprid and 6-chloronicotinic acid were purchased from Wako (Osaka, Japan).
Zolpidem, used as an internal standard (IS), was purchased from Sigma-Aldrich, Japan
(Tokyo, Japan). Other chemicals used were HPLC grade or analytical grade. Water was
purified using a Milli-Q A10 system (Millipore, MA, USA).
3. 2. Biological samples
Samples (whole blood from the heart and femoral vein, cerebrospinal fluid, vitreous
humor, and urine) for analysis were collected at the time of autopsy. Frozen human
whole blood was purchased from KAC Co. LTD. (Kyoto, Japan). All samples were
stored at -30 °C prior to analysis.
3. 3. Stock solutions
Stock solutions of imidacloprid and 6-chloronicotinic acid were prepared in
methanol at 1.0 mg/ml. The IS working solution (1.0 mg/ml zolpidem) was also
prepared in methanol.
3. 4. Sample preparation
Ten microliters of the IS working solution were placed into a microtube (1.5 ml)
and evaporated to dryness under a stream of nitrogen gas. An aliquot (100 µl) of the
liquid specimen was added to the tube and vortex-mixed. Two hundred microliters of
acetonitrile were added to the tube while vortex-mixing. The mixture was centrifuged at
12000 g for 5 min. The supernatant was transferred to another microtube and evaporated
to dryness under a stream of nitrogen gas at 40 °C. The residue was dissolved in 100 µl
of 15% acetonitrile-water (v/v) and centrifuged at 12000 g for 5 min. The supernatant
was then transferred to the appropriate glass autosampler vial insert and injected into the
HPLC system.
3.5. HPLC conditions for the analysis of imidacloprid
The HPLC system consisted of an Alliance 2695 separation module and 2996
photodiode array detector (Waters, MA, USA). The analytical column used was an
XTerra○R MS C18 2.1 × 150 mm, 3.5 µm (Waters, MA, USA). Column temperature was
set at 40 °C. Chromatograms were monitored at 270 nm, and injection volume was 5 µl.
The mobile phase consisted of acetonitrile-20 mM potassium dihydrogen phosphate
buffer (pH 3.0) (15:85, v/v), and flow rate was maintained at 0.2 ml/min.
3. 6. Calibration curve and recovery
A calibration curve was obtained by injection of a mixture of the imidacloprid stock
solution and the IS working solution diluted with 15% acetonitrile-water (v/v) at the
concentration of imidacloprid 1.0, 5.0, 10.0, 50.0, 100.0 and 200.0 μg/ml, respectively,
and 100 μg/ml of IS. The recovery rates were calculated according to the following
formula; recovery rate (%) = (peak area of imidacloprid of added blood or specimen –
average peak area of not added blood or specimen) / peak area of imidacloprid of the
standard mixture x 100.
4. Results and discussion
The contents of the plastic bottle, heart blood, urine, and the gastric were initially
subjected to qualitative analysis. Screening was performed using gas
chromatography/mass spectrometry (GC/MS) and HPLC/PDA. Imidacloprid was
identified in contents of the plastic bottle, gastric content and heart blood by GC/MS
(Fig. 2). Due to the imidacloprid peak appeared as tailing peak on total ion
chromatogram of GC/MS analysis using DB-5 MS capillary column, GC/MS was not
suitable for the quantitative analysis of imidacloprid. Imidacloprid was identified in all
specimens by HPLC/PDA (Fig. 3). Other basic, acidic, or neutral drugs, or agricultural
chemicals were not detected in any specimen.
Under the HPLC conditions for imidacloprid detection, the peaks of
6-chloronicotinic acid, imidacloprid, and zolpidem (IS) appeared at 5.3, 9.4, and 22.7
min, respectively, on the chromatogram monitored at 270 nm (Fig. 3-A). A peak for
heart blood was observed at 9.4 min (Fig. 3-B), and the UV spectrum of this peak (Fig.
3-C) matched that of imidacloprid. 6-Chloronicotinic acid was not identified in any
specimen. 6-Chloronicotinic acid spiked to the heart blood at a concentration of 0.1
µg/ml was detectable. Absence of peaks interfering with the IS peak was also confirmed
(Fig. 3-B).
A linear calibration curve for imidacloprid was obtained in the concentration range
of 1.0 to 200.0 µg/ml (r2 = 0.999). The detection limit of imidacloprid in blood was 0.02
µg/ml (S/N = 3).
The method was validated by performing replicate analysis (n = 3) on the drug-free
blank blood spiked with imidacloprid (1.0, 10.0, and 100.0 µg/ml). Table 1 shows the
validation data and recovery yield for the imidacloprid analysis. The recovery yield of
the IS was 94.4 ± 3.2%. The accuracy of the estimated concentrations of each specimen
was validated by analysis of the specimen spiked with imidacloprid (50.0 µg/ml). The
detected concentrations of samples spiked with 50.0 µg/ml imidacloprid, compared to
the untreated samples, increased from 50.1 µg/ml to 52.3 µg/ml. These values displayed
acceptable error ranges (less than 10 %).
Table 2 summarizes the concentrations of imidacloprid in each specimen. The
values were corrected so that the differences between the values obtained by subtracting
the values of the non-spiked sample from the values of the imidacloprid-spiked sample
were equal to 50.0 µg/ml.
The imidacloprid concentration in the femoral blood of our subject (105 µg/ml) was
the highest among its concentrations in plasma or blood in all the cases of imidacloprid
intoxication reported thus far (Table 3). The imidacloprid insecticide product, Admire○R
Flowable (containing 20% imidacloprid), was found in the subject’s garden shed. About
half of the contents (100 ml) of the bottle were used. A plastic bottle containing a small
volume of a cloudy liquid (with an ethanol concentration of 150 mg/ml and an
imidacloprid concentration of 50 mg/ml) was found near the decedent. We suspected
that the relatively high concentration in this case (105 µg/ml) was because of very high
ingestion of imidacloprid and ingestion of a mixture of an imidacloprid-based
insecticide with an alcoholic beverage, leading to enhanced imidacloprid absorption.
Imidacloprid penetration through the blood–brain barrier is poor [1, 2]. In our case,
imidacloprid was detected in the cerebrospinal fluid, and its concentration (58.5 μg/ml)
was approximately half of that measured in the femoral blood (105 μg/ml). This finding
is in agreement with the results of a study conducted in mice by Ford and Casida [16].
Because the binding affinity of imidacloprid to vertebrate nAChRs has been shown to
be weaker than that in the case of insects, the toxicity due to imidacloprid is low in
mammals, while imidacloprid is highly selective against insects [1, 3]. However, we
considered the high imidacloprid concentrations in the body to be lethal.
A high concentration of imidacloprid was detected in the gastric contents. The
analysis performed for common toxic substances showed negative results, and no injury
or disease that could be considered a cause of death was found at autopsy. Due to the
absence of evidence for an alternative cause of death (macroscopic or histological) and
the results of the toxicological tests, we concluded that the cause of death in this case
was imidacloprid intoxication.
References
[1] R. Solecki, http://www.inchem.org/documents/jmpr/jmpmono/2001pr07.htm.
[2] Yamamoto I, Yabuta G, Tomizawa M, Saito T, Miyamoto T, Kagabu S. Molecular
mechanism for selective toxicity of nicotinoids and neonicotinoids. J Pesticide Sci
1995; 20, 33-40.
[3] National Pesticide Information Center. Imidacloprid, Technical Fact Sheet
(1.800.855.7378). http://npic.orst.edu/factsheets/imidacloprid.pdf.
[4] Wu IW, Lin JL, Cheng ET. Acute poisoning with the neonicotinoid insecticide
imidacloprid in N-methyl pyrrolidone. J Toxicol Clin Toxicol 2001; 39: 617-21.
[5] Tamura M, Endo Y, Kuroki Y, Ohashi N, Yoshioka T, Sugimoto T. Investigation
and case study of imidacloprid insecticide caused poisoning. Chudoku Kenkyu 2002;
15: 309-12 (Japanese).
[6] Proença P, Teixeira H, Castanheira F, Pinheiro J, Monsanto PV, Marques EP, Vieira
DN. Two fatal intoxication cases with imidacloprid: LC/MS analysis. Forensic Sci Int
2005; 153: 75-80.
[7] Huang NC, Lin SL, Chou CH, Hung YM, Chung HM, Huang ST. Fatal ventricular
fibrillation in a patient with acute imidacloprid poisoning. Am J Emerg Med 2006; 24:
883-5.
[8] Agarwal R, Srinivas R. Severe neuropsychiatric manifestations and rhabdomyolysis
in a patient with imidacloprid poisoning. Am J Emerg Med 2007; 25: 844-5.
[9] Shadnia S, Moghaddam HH. Fatal intoxication with imidacloprid insecticide. Am J
Emerg Med 2008; 26: 634.e1-4.
[10] Mohamed F, Gawarammana I, Robertson TA, Roberts MS, Palangasinghe C,
Zawahir S, Jayamanne S, Kandasamy J, Eddleston M, Buckley NA, Dawson AH,
Roberts DM. Acute human self-poisoning with imidacloprid compound: a neonicotinoid
insecticide. PLoS One 2009; 4: e5127.
[11] Panigrahi AK, Subrahmanyam DK, Mukku KK. Imidacloprid poisoning: a case
report. Am J Emerg Med 2009; 27: 256.e5-6.
[12] Karatas AD. Severe central nervous system depression in a patient with acute
imidacloprid poisoning. Am J Emerg Med 2009; 27: 1171.e5-7.
[13] Yeh IJ, Lin TJ, Hwang DY. Acute multiple organ failure with imidacloprid and
alcohol ingestion. Am J Emerg Med 2010; 28: 255.e1-3.
[14] Iyyadurai R, George IA, Peter JV. Imidacloprid poisoning--newer insecticide and
fatal toxicity. J Med Toxicol 2010; 6: 77-8.
[15] Viradiya K, Mishra A. Imidacloprid poisoning. J Assoc Physicians India 2011; 59:
594-5.
[16] Ford KA, Casida JE. Chloropyridinyl neonicotinoid insecticides: diverse molecular
substituents contribute to facile metabolism in mice. Chem Res Toxicol 2006; 19:
944-51.
Figure legends
Fig. 1. Structures of imidacloprid, 6-chloronicotinic acid, and zolpidem (internal
standard).
Fig. 2. Total ion chromatograms of GC/MS analysis of 100.0 μg/ml imidacloprid (A)
and ethylacetate extract of the heart blood (B), and the mass spectra of peak 1 (C) and
peak 2 (D).
Fig. 3. Representative chromatograms of (A) 10.0 μg/ml 6-chloronicotinic acid (1),
imidacloprid (2), and zolpidem (3, IS) containing standard solution, (B) a heart blood
sample, and (C) the UV spectrum of the peak observed at 9.4 min on the chromatogram
of the heart blood sample.
Table 1. Imidacloprid assay validation in various samples and recoveries.
Sample n Added Detected* CV Recovery*
(µg /ml) (µg /ml) (%) (%)
Blank blood 3 1.0 1.2±0.0 0.7 85.9±2.3
3 10.0 9.7±0.0 0.2 86.7±0.7
3 100.0 98.1±0.3 0.3 87.5±1.3
Heart blood 2 0.0 98.9±0.1 0.1
2 50.0 149.5±2.1 1.4 93.4±5.9
Femoral blood 2 0.0 100.9±4.3 4.3
2 50.0 148.7±0.4 0.3 94.7±4.3
Cerebrospinal fluid 2 0.0 59.7±0.3 0.5
2 50.0 110.7±3.6 3.2 101.8±6.4
Vitreous humor 2 0.0 51.3±0.2 0.4
2 50.0 102.9±1.1 1.1 103.6±8.3
Urine 2 0.0 28.4±0.1 0.4
2 50.0 80.7±0.8 1.0 105.2±1.7
* The value is average±standard deviation.
21
Table 2. Imidacloprid and ethanol concentrations in various specimens. Sample Imidacloprid Ethanol (µg/ml) (mg/ml) Heart blood 97.5* 0.8 Femoral blood 105* 1.0 Cerebrospinal fluid 58.5* 1.4 Vitreous humor 49.6* 1.3 Urine 27.0* 1.4 Gastric content 1000 1.4
* The value is the average of duplicate analysis.
22
Table 3. Imidacloprid concentrations in plasma or blood reported in previous literature
on human cases of imidacloprid insecticide intoxication.
Reference No. Age Sex Outcome Concentration Sampling time Origin of
after ingestion the sample
(µg/ml) (h)
5 95 M Survival 3 24 Serum
5 50 M Survival 15 3.5 Serum
5 89 F Survival 23 0.5 Serum
5 62 M Survival 30.7 - Serum
5 78 M Survival 84.9 6 Serum
6 33 M Death 12.5 PM Blood
6 66 M Death 2.05 PM Blood
10 35 F Survival 44.6 5 Plasma
10 in 33 cases Survival 0.02–51.25 Plasma
-: not written, PM: postmortem